Abstract:
PHILADELPHIA — Current technologies, and those in the pipeline and beyond, could advance the management of diabetes comorbidities, George Grunberger, MD, FACP, FACE, said during a presentation at the Heart in Diabetes CME Conference.
Continuous glucose monitoring, wearable devices and other emerging technologies have the potential to not only improve glycemic control but also reduce the risk for diabetes-related complications, according to Grunberger, who is chairman of the Grunberger Diabetes Institute in Bloomfield Hills, Michigan.
At Heart in Diabetes, Healio spoke with Grunberger
